EW Q3 2020 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.1B+4.3% YoY

Gross Profit

$854M74.9% margin

Operating Income

$351M30.8% margin

Net Income

$325M28.5% margin

EPS (Diluted)

$0.52

QoQ Revenue Growth

+23.3%

Cash Flow

Operating Cash Flow

$216M

Free Cash Flow

$113M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$6.8B

Total Liabilities

$2.6B

Stockholders' Equity

$4.2B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.1B	+4.3%
Gross Profit	$854M	$789M	+8.3%
Operating Income	$351M	$287M	+22.5%
Net Income	$325M	$275M	+18.4%

Revenue Segments

Transcatheter Heart Valves

$745M65%

Surgical Heart Valve Therapy

$203M18%

Critical Care

$181M16%

Transcatheter Mitral And Tricuspid Therapies

$12M1%

Geographic Segments

UNITED STATES

$662M58%

Europe

$254M22%

JAPAN

$114M10%

Rest of World

$111M10%